NCT02354235View on ClinicalTrials.gov

Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)

PHASE3CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Teneligliptin

DRUG

Canagliflozin

DRUG

Placebo

Trial Locations (3)

Unknown

Reserch site, Kanto

Reserch site, Kinki

Reserch site, Tōhoku

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY